-
Clostridium difficile continues to emerge in a more pathogenic form with a new epidemiological profile. Particularly disturbing are new reports in four states of infections in patients previously thought to be at low risk for C. diff.
-
Synopsis: Three ICU patients receiving Saccharomyces boulardii (cerevisiae) therapy for treatment of Clostridium difficile colitis experienced fungemia. Review of 60 cases of S. cerevisiae fungemia reported in the literature found that risk factors included presence of a central venous catheter, intravenous or enteral alimentation, and receipt of S. cerevisiae as a probiotic.
-
Reports to the federal vaccine adverse event reporting system (VAERS) in the first two seasons of trivalent live, attenuated influenza vaccine (LAIV-T) use did not identify any unexpected serious risks with the vaccine when used according to approved indications, the authors report.
-
In the intensifying effort to immunize more health care workers against influenza, a precedent-setting battle is taking shape at Virginia Mason Medical Center (VMMC) in Seattle. In what is thought to be the first hospital in the United States to take such action, Virginia Mason officials have mandated annual flu shots as a condition of health care employment.
-
If you have scarce supplies of influenza vaccine, which health care workers (HCWs) would you immunize? Not an easy question, and the answers will certainly vary by institution.
-
-
-
Any light shed on resistant staph in the community by the Association for Professionals in Infection Control and Epidemiology's national prevalence survey will be most welcome.
-
Manufacturers are expecting to produce and distribute more than 100 million doses of influenza vaccines in the United States through early January 2007, the Centers for Disease Control and Prevention reports.
-
Infection control professionals throughout the country are being urged to participate in an unprecedented national prevalence survey this month as part of a long-range goal to eradicate the scourge of methicillin-resistant Staphylococcus aureus (MRSA) infections.
